Streetbeat News

Stock Prices

PTON

Peloton Interactive shares rose following a report of better-than-expected Q1 sales.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:06 am

NVRI

Enviri has announced its expected Q4 adjusted EPS to be between $(0.03) and $(0.14), which is below the market estimate of $(0.03).

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:06 am

CIFR

Cipher Mining reported a Q3 2024 adjusted EPS of $(0.01), beating the estimate of $(0.08), but sales of $24.10M missed the $29.22M estimate. This represents a significant decrease in both earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:05 am

MDGL

Madrigal Pharmaceuticals reported better-than-expected Q3 2024 results, with a GAAP EPS of $(4.92) beating the estimate of $(6.92) and sales of $62.175 million surpassing the $33.656 million estimate.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:05 am

COP

ConocoPhillips' Board of Directors has approved an increase in the company's share repurchase authorization by up to $20 billion.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:05 am

DFIN

Donnelley Financial Solutions (NYSE:DFIN) reported Q3 2024 earnings per share of $0.48, missing the analyst estimate of $0.76 by 36.84%. Sales were $179.5M, slightly below the $181.433M estimate and down 0.28% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:05 am

PTON

Peloton has projected its FY25 EBITDA to be between $240 million and $290 million, indicating potential financial improvement.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:04 am

NVRI

Enviri (NYSE:NVRI) reported Q3 2024 earnings per share of $(0.01), missing the analyst estimate of $0.07. Sales were $573.627M, below the expected $613.625M, but up 9.35% from last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:04 am

OTEX

Open Text reported its Q1 2025 financial results, with adjusted EPS of $0.93 beating the estimate of $0.80, but sales of $1.269 billion missing the estimate of $1.282 billion.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:04 am

INSM

Insmed reported Q3 2024 earnings with a GAAP EPS of $(1.27), missing the estimate of $(1.21). However, sales were $93.42M, beating the $93.01M estimate and showing an 18.15% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:04 am